US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Decoy Therapeutics Inc

2.89

+0.18006.64%

Post-market: 2.85-0.0395-1.37%18:01 EDT

Volume:25.93K

Turnover:73.84K

Market Cap:1.89M

PE:-0.07

High:2.95

Open:2.87

Low:2.77

Close:2.71

52wk High:70.80

52wk Low:2.59

Shares:655.19K

Float Shares:586.42K

Volume Ratio:0.47

T/O Rate:4.42%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-40.3963

EPS(LYR):-129.1004

ROE:-827.77%

ROA:-73.35%

PB:0.44

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Decoy Therapeutics Holds Special Shareholder Meeting with Quorum Present

Decoy Therapeutics Q2 Net Loss Widens 148% to $2.37 Million; Revenue Turns to $227,629 from no Revenue

Decoy Therapeutics Announces Special Shareholder Meeting Via Webcast

Decoy Therapeutics Expands IP Portfolio with 1 Granted US Patent, 19 Applications Pending

Decoy Therapeutics Files Form 3 for Director Patricia G. Gauthier

Decoy Therapeutics D-MAV Candidate Shows in Vitro Activity Against Ebola Zaire Virus

Decoy Therapeutics Announces Special Shareholder Meeting

Decoy Therapeutics Holds Annual Shareholder Meeting

Decoy Therapeutics Adds Moderna Executive Patricia Gauthier to Board

Press Release: Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors

Decoy Therapeutics Files to Register Up to 3.77 Million Shares for Resale

MT Newswires Live

Top Premarket Decliners

MT Newswires Live

Why Is Penny Stock Decoy Therapeutics (DCOY) Up Today?

NASDAQ Trade Halt Volatility Trading Pause at 09:37 Am

Decoy Therapeutics Inc trading halted, volatility trading pause

Top Premarket Gainers

MT Newswires Live

Decoy Therapeutics Enters $3.5 Million PIPE Priced at USD 5.91 Per Share

Press Release: Decoy Therapeutics, Inc. Announces up to $21 Million Private Placement Financing

Decoy Therapeutics posts investor presentation on D-MAV multi-viral fusion inhibitor platform

Decoy Therapeutics Inc trading halted, volatility trading pause

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/DCOY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"DCOY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DCOY\",,,,,undefined,":{"symbol":"DCOY","market":"US","secType":"STK","nameCN":"Decoy Therapeutics Inc","latestPrice":2.89,"timestamp":1789588800000,"preClose":2.71,"halted":0,"volume":25930,"hourTrading":{"tag":"盘后","latestPrice":2.8505,"preClose":2.89,"latestTime":"18:01 EDT","volume":8,"amount":23.0416008,"timestamp":1789596097791,"change":-0.0395,"changeRate":-0.013668,"amplitude":0.013668},"delay":0,"changeRate":0.06642066420664212,"floatShares":586415,"shares":655185,"eps":-40.396286,"marketStatus":"Post-Mkt","change":0.18,"latestTime":"09-16 19:11:35 EDT","open":2.87,"high":2.95,"low":2.7698,"amount":73836.388075,"amplitude":0.066494,"askPrice":3.2,"askSize":100,"bidPrice":2.7,"bidSize":19,"shortable":3,"etf":0,"ttmEps":-40.396286,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"listingDate":1422507600000,"exchange":"NASDAQ","adjPreClose":2.71,"preHourTrading":{"tag":"盘前","latestPrice":2.82,"preClose":2.71,"latestTime":"09:28 EDT","volume":238,"amount":644.1900304,"timestamp":1789565281096,"change":0.11,"changeRate":0.04059,"amplitude":0.066421},"postHourTrading":{"tag":"盘后","latestPrice":2.8505,"preClose":2.89,"latestTime":"18:01 EDT","volume":8,"amount":23.0416008,"timestamp":1789596097791,"change":-0.0395,"changeRate":-0.013668,"amplitude":0.013668},"volumeRatio":0.465495},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DCOY\",,,,,undefined,":{"symbol":"DCOY","floatShares":586415,"roa":"-73.35%","roe":"-827.77%","lyrEps":-129.100415,"volumeRatio":0.465495,"shares":655185,"dividePrice":0,"high":2.95,"amplitude":0.066494,"preClose":2.71,"low":2.7698,"week52Low":2.588,"pbRate":"0.44","psRate":"8.32","week52High":70.8,"institutionHeld":0,"latestPrice":2.89,"committee":-0.680672,"eps":-40.396286,"divideRate":0,"volume":25930,"delay":0,"ttmEps":-40.396286,"open":2.87,"prevYearClose":7.7856,"prevWeekClose":2.67,"prevMonthClose":3.05,"prevQuarterClose":7.19,"fiveDayClose":2.76,"twentyDayClose":3.67,"sixtyDayClose":6.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DCOY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"DCOY","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-4.46},{"market":"US","date":"2026-05-08","symbol":"DCOY","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"post","actualEps":-4.18},{"market":"US","date":"2026-03-31","symbol":"DCOY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2026-03-09","symbol":"DCOY","defaultRemindTime":1773063000000,"type":"split","dateTimestamp":1773028800000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DCOY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DCOY\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DCOY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DCOY","date":"2026-09-15","current":-0.071541,"percent":0.982353,"low":-1.594527,"twenty":-0.869974,"median":-0.252238,"eighty":-0.178362,"high":-0.119252,"avg":-0.460229,"sd":0.346974,"marketCap":1775551},"quantilePoints":[{"date":"2026-01-09","current":-0.982229,"twenty":-1.053663,"median":-1.026876,"eighty":-1.000088,"marketCap":4915816},{"date":"2026-01-16","current":-1.227403,"twenty":-1.203881,"median":-1.071522,"eighty":-1.040856,"marketCap":6142855},{"date":"2026-01-23","current":-0.957354,"twenty":-1.160688,"median":-1.045754,"eighty":-0.982229,"marketCap":4791324},{"date":"2026-01-30","current":-1.05749,"twenty":-1.109791,"median":-1.050666,"eighty":-0.994985,"marketCap":5292482},{"date":"2026-02-06","current":-0.790885,"twenty":-1.101882,"median":-1.039631,"eighty":-0.91832,"marketCap":3958189},{"date":"2026-02-13","current":-0.956844,"twenty":-1.071522,"median":-0.994921,"eighty":-0.926101,"marketCap":4788771},{"date":"2026-02-20","current":-1.018456,"twenty":-1.060296,"median":-0.989117,"eighty":-0.939163,"marketCap":5097126},{"date":"2026-02-27","current":-0.871249,"twenty":-1.05596,"median":-0.982229,"eighty":-0.908242,"marketCap":4360392},{"date":"2026-03-06","current":-0.74305,"twenty":-1.047719,"median":-0.957099,"eighty":-0.869974,"marketCap":3718783},{"date":"2026-03-13","current":-0.796199,"twenty":-1.041162,"median":-0.954292,"eighty":-0.863596,"marketCap":3984784},{"date":"2026-03-20","current":-0.84935,"twenty":-1.039708,"median":-0.934265,"eighty":-0.844716,"marketCap":4250791},{"date":"2026-03-27","current":-0.746769,"twenty":-1.027385,"median":-0.915268,"eighty":-0.830428,"marketCap":3737398},{"date":"2026-04-02","current":-0.671826,"twenty":-1.020803,"median":-0.90314,"eighty":-0.800664,"marketCap":3362328},{"date":"2026-04-10","current":-0.254968,"twenty":-1.004373,"median":-0.87465,"eighty":-0.787058,"marketCap":3191808},{"date":"2026-04-17","current":-0.249443,"twenty":-0.994908,"median":-0.869974,"eighty":-0.73327,"marketCap":3122652},{"date":"2026-04-24","current":-0.230321,"twenty":-0.987969,"median":-0.855197,"eighty":-0.507377,"marketCap":2883266},{"date":"2026-05-01","current":-0.257092,"twenty":-0.982688,"median":-0.845098,"eighty":-0.256242,"marketCap":3218406},{"date":"2026-05-08","current":-0.243919,"twenty":-0.982229,"median":-0.84006,"eighty":-0.250421,"marketCap":3053496},{"date":"2026-05-15","current":-0.184485,"twenty":-0.974422,"median":-0.810018,"eighty":-0.248296,"marketCap":2404495},{"date":"2026-05-22","current":-0.262442,"twenty":-0.962099,"median":-0.79992,"eighty":-0.247659,"marketCap":3420554},{"date":"2026-05-29","current":-0.322848,"twenty":-0.95715,"median":-0.794073,"eighty":-0.248169,"marketCap":4207866},{"date":"2026-06-05","current":-0.27387,"twenty":-0.956742,"median":-0.781317,"eighty":-0.248169,"marketCap":3569505},{"date":"2026-06-12","current":-0.24081,"twenty":-0.95567,"median":-0.74491,"eighty":-0.247404,"marketCap":3138611},{"date":"2026-06-18","current":-0.24285,"twenty":-0.952787,"median":-0.706406,"eighty":-0.245537,"marketCap":3165209},{"date":"2026-06-26","current":-0.241544,"twenty":-0.945899,"median":-0.6697,"eighty":-0.244973,"marketCap":3148186},{"date":"2026-07-02","current":-0.311012,"twenty":-0.942429,"median":-0.364072,"eighty":-0.244891,"marketCap":4053596},{"date":"2026-07-10","current":-0.255707,"twenty":-0.926101,"median":-0.334889,"eighty":-0.244891,"marketCap":3332779},{"date":"2026-07-17","current":-0.244483,"twenty":-0.91832,"median":-0.322848,"eighty":-0.24285,"marketCap":3186488},{"date":"2026-07-24","current":-0.201627,"twenty":-0.915268,"median":-0.304685,"eighty":-0.239993,"marketCap":2627921},{"date":"2026-07-31","current":-0.159996,"twenty":-0.910668,"median":-0.29693,"eighty":-0.235273,"marketCap":2085314},{"date":"2026-08-07","current":-0.16571,"twenty":-0.904416,"median":-0.286523,"eighty":-0.233302,"marketCap":2159790},{"date":"2026-08-14","current":-0.129959,"twenty":-0.896201,"median":-0.26684,"eighty":-0.229711,"marketCap":1877847},{"date":"2026-08-21","current":-0.148725,"twenty":-0.881334,"median":-0.262442,"eighty":-0.225153,"marketCap":2149006},{"date":"2026-08-28","current":-0.134668,"twenty":-0.872609,"median":-0.257114,"eighty":-0.215096,"marketCap":1945899},{"date":"2026-09-04","current":-0.130588,"twenty":-0.870229,"median":-0.255393,"eighty":-0.199995,"marketCap":1886932},{"date":"2026-09-11","current":-0.123786,"twenty":-0.869974,"median":-0.254968,"eighty":-0.182689,"marketCap":1788655},{"date":"2026-09-15","current":-0.122879,"twenty":-0.869974,"median":-0.252238,"eighty":-0.178362,"marketCap":1775551}],"updateTime":1789600295326},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DCOY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667622972","title":"Decoy Therapeutics Holds Special Shareholder Meeting with Quorum Present","url":"https://stock-news.laohu8.com/highlight/detail?id=2667622972","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667622972?lang=en_us&edition=fundamental","pubTime":"2026-09-16 05:01","pubTimestamp":1789506092,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics holds special shareholder meeting with quorum presentShareholders met on Sept. 14, 2026 to vote on two capital structure items.Backed issuing common stock upon exercise of Series A,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nNDL4Xsqwl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659190093","title":"Decoy Therapeutics Q2 Net Loss Widens 148% to $2.37 Million; Revenue Turns to $227,629 from no Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2659190093","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659190093?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:17","pubTimestamp":1786565856,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics Q2 net loss widens 148% to $2.37 million; revenue turns to $227,629 from no revenueDecoy Therapeutics posted a GAAP net loss of $2.37 million for the quarter ended June 30, 2026, wi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL7XSR7P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657567926","title":"Decoy Therapeutics Announces Special Shareholder Meeting Via Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2657567926","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657567926?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:12","pubTimestamp":1785877949,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics announces special shareholder meeting via webcastDecoy Therapeutics will hold a virtual special stockholder meeting on Sept. 14, 2026.Vote scheduled on allowing exercise of Series A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL39dyNj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656714533","title":"Decoy Therapeutics Expands IP Portfolio with 1 Granted US Patent, 19 Applications Pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2656714533","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656714533?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:01","pubTimestamp":1785762092,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics expands IP portfolio with 1 granted US patent, 19 applications pendingDecoy Therapeutics expanded its antiviral intellectual property portfolio to seven patent families, including o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL7DHjmc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656391608","title":"Decoy Therapeutics Files Form 3 for Director Patricia G. Gauthier","url":"https://stock-news.laohu8.com/highlight/detail?id=2656391608","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656391608?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:52","pubTimestamp":1785531134,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics files Form 3 for director Patricia G. GauthierDecoy Therapeutics reported director Patricia G. Gauthier as a new insider in an initial Form 3 filing dated July 14, 2026.Disclaimer:T","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL6FxNDP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654455048","title":"Decoy Therapeutics D-MAV Candidate Shows in Vitro Activity Against Ebola Zaire Virus","url":"https://stock-news.laohu8.com/highlight/detail?id=2654455048","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654455048?lang=en_us&edition=fundamental","pubTime":"2026-07-27 21:03","pubTimestamp":1785157421,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics D-MAV candidate shows in vitro activity against Ebola Zaire virusDecoy Therapeutics reported a D-MAV candidate showed in vitro activity against wild-type Ebola Zaire in tests at Tex","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL870Ldb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654032655","title":"Decoy Therapeutics Announces Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2654032655","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654032655?lang=en_us&edition=fundamental","pubTime":"2026-07-25 04:06","pubTimestamp":1784923608,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics announces special shareholder meetingDecoy Therapeutics will hold a virtual special shareholder meeting on Sept. 14, 2026.Vote set on allowing exercise of Series A, Series B, Series","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDLtQYV9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651499597","title":"Decoy Therapeutics Holds Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2651499597","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651499597?lang=en_us&edition=fundamental","pubTime":"2026-07-16 05:15","pubTimestamp":1784150115,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics holds annual shareholder meetingDecoy Therapeutics held its annual shareholder meeting on July 14, 2026.Shareholders backed the board’s slate of Class II director nominees.Sharehold","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL6MYGTW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651466644","title":"Decoy Therapeutics Adds Moderna Executive Patricia Gauthier to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2651466644","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651466644?lang=en_us&edition=fundamental","pubTime":"2026-07-15 21:25","pubTimestamp":1784121940,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics adds Moderna executive Patricia Gauthier to boardDecoy Therapeutics stockholders elected Patricia Gauthier as a Class II director at the July 14, 2026 annual meeting.Gauthier has be","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDLc52tY0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","MRNA","BK4532","BK4533","MRNX","DCOY","GNOM","BK4588","BK4548","BK4534","BK4501","BK4585","BK4139","LGHT","MRNY","WDNA","IDNA","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651466612","title":"Press Release: Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2651466612","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651466612?lang=en_us&edition=fundamental","pubTime":"2026-07-15 21:25","pubTimestamp":1784121900,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., July 15, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs(TM)), a new category of antivirals engine","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4555","BK4099","BK4588","BK4585","03160","BK4139","BK4604","BK4007","BK4539","LENZ","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650493137","title":"Decoy Therapeutics Files to Register Up to 3.77 Million Shares for Resale","url":"https://stock-news.laohu8.com/highlight/detail?id=2650493137","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650493137?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:45","pubTimestamp":1783716321,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics  on Friday filed a statement to register the resale of up to 3.77 million shares of common stock issuable upon the exercise of warrants issued in a private placement that closed on June 29.The company said it is not selling any shares under the registration statement and will not receive proceeds from sales by the selling stockholders, though it may receive proceeds from any cash exercise of the warrants.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DCOY","BK4007","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647755810","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2647755810","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647755810?lang=en_us&edition=fundamental","pubTime":"2026-06-30 19:35","pubTimestamp":1782819325,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics  shares were down 37% in Tuesday premarket activity, following the previous session's 8% gain.GMEX Robotics  stock was down 34% after the company said it would implement a 1-for-9 share consolidation of its Class A and Class B ordinary shares.Universe Pharmaceuticals  shares were down 29% after the previous session's 311% rally.Nuvectis Pharma  stock was down 24% after the company priced a secondary offering of 5 million common shares at $20 per share.Decoy Therapeutics  shares were down 21%, following the earlier session's 74% gain.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4200","GMEX","BK4539","UPC","NVCT","BK4007","UNCY","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647130969","title":"Why Is Penny Stock Decoy Therapeutics (DCOY) Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2647130969","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647130969?lang=en_us&edition=fundamental","pubTime":"2026-06-30 01:47","pubTimestamp":1782755240,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics stock rallied on Monday alongside news of new funding for the company.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-penny-stock-decoy-therapeutics-dcoy-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-penny-stock-decoy-therapeutics-dcoy-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DCOY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647372495","title":"NASDAQ Trade Halt Volatility Trading Pause at 09:37 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2647372495","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647372495?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:37","pubTimestamp":1782740239,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 09:37 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nAQN2M63PJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647372737","title":"Decoy Therapeutics Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2647372737","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647372737?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:35","pubTimestamp":1782740122,"startTime":"0","endTime":"0","summary":"09:31 EDT Decoy Therapeutics (DCOY) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, mar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/decoy-therapeutics-inc-trading-halted-volatility-trading-pause-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/decoy-therapeutics-inc-trading-halted-volatility-trading-pause-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647224375","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2647224375","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647224375?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:05","pubTimestamp":1782731124,"startTime":"0","endTime":"0","summary":"Universe Pharmaceuticals  shares were up 170% in Monday premarket activity after the company said late Friday it agreed to acquire Best Praise International for about $10.8 million.Decoy Therapeutics  stock was 146% higher after the company agreed to a private placement of about $3.5 million with a single healthcare-focused institutional investor.Sagtec Global  shares were up 26%, recovering from a 27% decline in Friday's session.Comcast  stock was 22% higher after the company said it plans to separate into two publicly traded companies through a tax-free spin-off of its NBCUniversal and Sky businesses.Palatin Technologies  shares were up 22%, adding to a 9% gain in the previous session.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1150488218.USD","BK4550","LU0868494617.USD","LU0208291251.USD","LU0980610538.SGD","LU1244550494.USD","LU1489326972.SGD","LU1244550577.SGD","LU0868494708.USD","CMCSA","LU0128525929.USD","LU0320765489.SGD","IE00B894F039.SGD","BK4566","BK4534","LU1894683348.USD","LU0708994859.HKD","PTN.AU","LU1201861249.SGD","LU1244550221.USD","SAGT","DCOY","BK4139","LU0985489474.SGD","LU1150488135.SGD","LU0942090050.USD","LU0878866978.SGD","PTN","BK4585","BK4598","LU0310800379.SGD","LU0648001328.SGD","LU0029864427.USD","BK4507","LU0433182093.SGD","LU1074936037.SGD","LU1267930573.SGD","BK4588","LU0070302665.USD","BK4007","BK4023","UPC","BK4100","BK4115","LU1059921491.USD","BK7095","IE00BSNM7G36.USD","LU0068578508.USD","IE00B19Z9Z06.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646267395","title":"Decoy Therapeutics Enters $3.5 Million PIPE Priced at USD 5.91 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2646267395","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646267395?lang=en_us&edition=fundamental","pubTime":"2026-06-27 08:12","pubTimestamp":1782519137,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics enters $3.5 million PIPE priced at USD 5.91 per shareDecoy Therapeutics entered a PIPE with one healthcare-focused institutional investor for USD 3.5 million in upfront gross procee","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260627:nNDL8nzTY3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646395269","title":"Press Release: Decoy Therapeutics, Inc. Announces up to $21 Million Private Placement Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2646395269","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646395269?lang=en_us&edition=fundamental","pubTime":"2026-06-27 08:12","pubTimestamp":1782519120,"startTime":"0","endTime":"0","summary":"HOUSTON, June 26, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) (the \"Company\" or \"Decoy\"), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs(TM)), a new category o","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","LENZ","BK4139","BK4604","TM","BK4007","BK4585","DCOY","BK4555","BK4588","BK4539","BK4099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645043589","title":"Decoy Therapeutics posts investor presentation on D-MAV multi-viral fusion inhibitor platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2645043589","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645043589?lang=en_us&edition=fundamental","pubTime":"2026-06-22 12:03","pubTimestamp":1782101006,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics highlighted its Designable Multi-Antivirals platform targeting viral fusion inhibition, aiming for one drug to cover multiple viruses.Presentation cited a structurally conserved target across 250+ human-infecting viruses, with programs designed to address 70%+ of annual virus-positive respiratory infections.Non-dilutive funding totaled $6.5 million, positioned as support from global health, technology, and government organizations.Company pointed to $5.7 billion in 2024 Paxlovid sales as evidence of a large, persistent antiviral market driven by mutation risk.Development plan emphasized two clinical programs in 24 months, enabled by an AI/ML design-build-test-learn workflow on Google Cloud.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investme","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL6wXmd0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642633499","title":"Decoy Therapeutics Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2642633499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642633499?lang=en_us&edition=fundamental","pubTime":"2026-06-09 23:45","pubTimestamp":1781019930,"startTime":"0","endTime":"0","summary":"11:42 EDT Decoy Therapeutics (DCOY) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, mar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/decoy-therapeutics-inc-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/decoy-therapeutics-inc-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}